Computational pharmacogenomic screen identifies drugs that phenocopy dipyridamole and potentiate anti-breast cancer activity of statins
Jenna E. van Leeuwen(University of Toronto), Deena M.A. Gendoo(University of Birmingham)
Cited by 0
Related Papers
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
|Cancer Cell|2016|259
The molecular basis of breast cancer pathological phenotypes
|The Journal of Pathology|2016|114
Computational pharmacogenomics screen identifies synergistic statin-compound combinations as anti-breast cancer therapies
|bioRxiv (Cold Spring Harbor Laboratory)|2020|2